Medtronic was recently hit with a $382M verdict in a monopoly suit brought by Applied Medical. MD+DI Senior Editor Amanda Pedersen weighs in on the case.
Learn why cytotoxicity test failures are common in medical devices and discover systematic approaches to identify root causes ...
FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...
Tecan CDMO integrates optics, electronics, and fluidics via a DFX‑driven NPI and deterministic testing to deliver zero‑defect ...
Integra says there is no credible evidence to show any causal connection between TruDi, AI, and any alleged injuries. More ...
Oura partners with femtech company Mira to integrate hormone testing data with wellness tracking, targeting the booming $60B ...
Edwards Lifesciences reports strong Q4 2025 results with 13.3% sales growth to $1.57B, driven by TAVR and TMTT performance ...
TPC CFO Roy Barnes discusses AI implementation, medical device reshoring realities, and manufacturing risks companies face in ...
FDA escalates Johnson&Johnson brain coil recall to Class I after device failures linked to patient death and serious injuries ...
The Leica CM1950 Cryostat with DualEcoTec Cooling System, for in vitro diagnostic use, prioritizes technician well-being by ...
Neurent Medical, a company that has created a minimally invasive solution to treat chronic rhinitis, has raised $74 million ...
Medline recalls 4,300 blood culture kits due to packaging defects that could cause sterility issues with BD ChloraPrep ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results